Fabricant: Gap between NDI numbers and submissions is too big 'no matter how you slice it'

It might be controversial, but the FDA's draft guidance on new dietary ingredients (NDIs) does not mean the end of the dietary supplements trade as we know it, insists Daniel Fabricant in an exclusive interview with NutraIngredients-USA at SupplySide West.

Talking with Stephen Daniells, Dr Fabricant fielded questions on the FDA's assessment on the time required for a notification, a definite grandfathered list, FDA's resources to cope with an anticipated avalanche of submissions, probiotics, and much more...

Related Topics

Regulation & policy

Related news

'Master Files' top list of NDI comments of note… so far

The proposal to use Master Files for IP protection and to expedite the notification process is attracting attention within FDA, as the agency considers comments submitted in response to its controversial NDI draft guidance.

Trade to FDA: Don’t leave us in limbo on NDI guidance

While the Food and Drug Administration (FDA) will need time to process the expected tidal wave of comments on its draft guidance on new dietary ingredients (NDIs), the supplements industry should not be left in regulatory “limbo” for long, trade...